Retrospective study on intervention of traditional Chinese medicine in osteoporosis and related pain diseases.
10.19540/j.cnki.cjcmm.20250213.702
- Author:
Yi-Run LI
1
;
Li LI
2
;
Yin-Qiu GAO
3
;
Cui-Ling DONG
3
;
Xing-Jiang XIONG
4
;
Xiao-Chen YANG
3
Author Information
1. Pain Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China Beijing University of Chinese Medicine Beijing 100029, China.
2. Cadre Health Care Office, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
3. Pain Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
4. Cardiology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
- Publication Type:English Abstract
- Keywords:
osteoporosis;
osteoporotic pain;
pain;
prescriptions;
traditional Chinese medicine
- MeSH:
Humans;
Osteoporosis/genetics*;
Drugs, Chinese Herbal/administration & dosage*;
Retrospective Studies;
Bone Density/drug effects*;
Medicine, Chinese Traditional;
Pain/metabolism*;
Animals
- From:
China Journal of Chinese Materia Medica
2025;50(11):3180-3188
- CountryChina
- Language:Chinese
-
Abstract:
Osteoporosis(OP) is a metabolic bone disorder characterized by reduced bone mass and degenerative bone tissue. Osteoporotic pain(OPP) is its most common clinical symptom, significantly affecting the quality of life of patients. With the limitations of modern medical treatments and the intensification of aging, it is imperative to explore more cost-effective interventions for OPP. This paper, based on databases such as China National Knowledge Infrastructure(CNKI), VIP, Wanfang, BioMed, and Web of Science, uncovered the connection between the pathogenesis of OPP in traditional Chinese medicine(TCM) and modern medical mechanisms and retrospectively summarized the basic and clinical research methods and evidence of TCM prescriptions in the treatment of OP and related pain diseases. Studies have shown that TCM prescriptions, focusing on treatments such as nourishing the kidney, strengthening the spleen, and activating blood circulation to remove blood stasis, can significantly improve pain symptoms, increase bone mineral density(BMD), and adjust bone metabolic indicators such as C-terminal telopeptide of type Ⅰ collagen(CTX), serum bone Gla-protein(S-BGP), and alkaline phosphatase(ALP). The mechanisms of action of TCM prescriptions in treating OP and improving OPP symptoms were related to signaling pathways such as Wnt/β-catenin, nuclear factor kappa-B(NF-κB), mitogen-activated protein kinase(MAPK), phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt), and the osteoprotegerin(OPG)/receptor activator of NF-κB(RANK)/receptor activator of NF-κB ligand(RANKL) axis. Further strengthening the accumulation and analysis of clinical data, rigorously designing and conducting randomized controlled trials of TCM treatments for OPP with large sample sizes, standardizing outcome measures in basic and clinical research by using methods such as the core outcome set(COS), and incorporating mass spectrometry and omics approaches to uncover more potential active components and mechanisms may contribute to a deeper exploration of the advantages and essence of TCM prescriptions in the treatment of OPP.
